Effectiveness of itraconazole on clinical symptoms and radiologic findings in patients with recurrent chronic rhinosinusitis and nasal polyposis

Authors
Mostafa Hashemi
Akram Fereidani
Nezamoddin Berjis
Sayyed Ahmad Reza Okhovat
Afrooz Eshaghain
Department of Otorhinolaryngology, Kashani Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: This study was done to evaluate the effect of itraconazole on clinical symptoms and radiologic findings in patients with chronic rhinosinusitis and nasal polyposis after surgery.
Materials and Methods: In a clinical trial which was conducted in Alzahra and Kashani hospitals, from November 2011 to December 2012, 22 patients with recurrent postsurgical chronic sinusitis and polyposis entered the study. At the start of the study demographic data, subjective clinical symptoms (severity of rhinorrhea, nasal obstruction, hyposmia, and dyspnea), quality of life (QoL) by sinonasal outcome test-20 (SNOT-20), serum immunoglobulin E (IgE), and score of computed tomography (CT) scan (by Lund-Mackay) were recorded. Itraconazole (100 mg, twice per day) prescribed for 3 months and patients were followed in the 1 st , 3 rd , and 6 th months. Liver enzyme tests and side effects were evaluated monthly.
Results: Severity of rhinorrhea, nasal obstruction, hyposmia, dyspnea, and QoL (by SNOT-20) improved during 3 months of treatment. Serum IgE was 265 (±277) at the start of the study, and decrease to 193 (±183) after 3 month. After 3 month, Lund-Mackay score of CT scan lowered from 19 (±4) to 15 (±6) (P < 0.05). At the 6 th month, severity of clinical symptoms except dyspnea and QoL were better than first evaluation.
Conclusion: This study showed the beneficial effect of 3-month itraconazole treatment on clinical symptoms and radiologic findings and QoL in patients with recurrent postsurgical chronic rhinosinusitis and nasal polyposis.

Keywords

1. Benninger MS. The pathogenesis of rhinosinusitis In: Flint PW, Haughey BH, Lund VJ, Niparko J, Richardson MA, Robbins KT, Thomas JR, editors. Cummings Otolaryngology: Head and Neck Surgery. 5 th ed., vol 47. Maryland Heights: Mosby, Elsevier; 2010. p. 705-7.  Back to cited text no. 1
    
2. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117:S1-7.  Back to cited text no. 2
    
3. Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129:S1-32.  Back to cited text no. 3
    
4. Khalid AN, Quraishi SA, Kennedy DW. Long-term quality of life measures after functional endoscopic sinus surgery. Am J Rhinol 2004;18:131-6.  Back to cited text no. 4
    
5. Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408-14.  Back to cited text no. 5
    
6. Jain S, Das S, Gupta N, Malik JN. Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India. Med Mycol 2013;51:164-9.  Back to cited text no. 6
    
7. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-84.  Back to cited text no. 7
    
8. Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. 'Eosinophilic fungal rhinosinusitis': A common disorder in Europe? Laryngoscope 2003;113:264-9.  Back to cited text no. 8
    
9. Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, Kephart G, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002;127:377-83.  Back to cited text no. 9
    
10. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G, et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: A double blind, placebo-controlled study. Laryngoscope 2005;115:1793-9.  Back to cited text no. 10
    
11. Hamilos DL, Lund VJ. Etiology of chronic rhinosinusitis: The role of fungus. Ann Otol Rhinol Laryngol Suppl 2004;193:27-31.  Back to cited text no. 11
    
12. Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005;115:601-6.  Back to cited text no. 12
    
13. Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg 2008;37:870-4.  Back to cited text no. 13
    
14. Bachert C, Gevaert P, van Cauwenberge PA. Middleton's allergy: Principles and practice. In: Adamko DJ, Adkinson NF Jr, Akdis CA, Amrani Y, Apter AJ, Avila-Tang E, editors. Nasal Polyps and Rhinosinusitis. 7 th ed. Philadelphia: Mosby; 2008. p. 56-991.  Back to cited text no. 14
    
15. Ricchetti A, Landis BN, Giger R, Zheng C, Lacroix JS. Effect of local antifungal treatment on nasal polyposis. Otorhinoloaryngologia 2002/2003;12:48-51.  Back to cited text no. 15
    
16. Hashemi SM, Mokhtarinejad F, Karim M, Okhovat SH. Does amphotericin B nasal douching help prevent polyp recurrence following functional endoscopic sinus surgery? J Res Med Sci 2011;16:74-8.  Back to cited text no. 16
[PUBMED]  Medknow Journal  
17. Yagi HI, Gumaa SA, Shumo AI, Abdalla N, Gadir AA. Nasosinus aspergillosis in Sudanese patients: Clinical features, pathology, diagnosis, and treatment. J Otolaryngol 1999;28:90-4.  Back to cited text no. 17
    
18. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310-44.  Back to cited text no. 18
    
19. Mohr J, Johnson M, Cooper T, Lewis JS, Ostrosky-Zeichner L. Current options in antifungal pharmacotherapy. Pharmacotherapy 2008;28:614-45.  Back to cited text no. 19
    
20. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:41-7.  Back to cited text no. 20
    
21. Ali SN, Zangi M, Naeini PS, Haj Fathali AR. Evaluating diagnostic value of clinical symptoms and signs for sinusitis by CT scan at Milad hospital. JAUMS 2007;5:1245-49.  Back to cited text no. 21
    
22. Rains BM 3 rd , Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003;17:1-8.  Back to cited text no. 22
    
23. Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy 2009;23:303-6.  Back to cited text no. 23
    
24. Lal D, Stankiewicz JA. Antifungal treatment and chronic rhinosinusitis. Curr Allergy Asthma Rep 2009;9:227-31.  Back to cited text no. 24
    
25. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62
Advanced Biomedical Research
Volume 2014, August
August 2014
Pages 1-5